TROP2-directed CAR-NK therapy with TGFBR2 knockout
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for TROP2-directed CAR-NK therapy with TGFBR2 knockout, covering 2026-04-23 to 2026-04-23. Get the full timeline:
Most recent: Clinical Trial Update: Dual Administration Of Intraperitoneal And Intravenous TROP2-Directed CAR-NK With TGF-Beta Receptor 2 (TGFBR2) Knock Out (KO) Therapy For Colorectal Cancer-Related Peritoneal Carcinomatosis: A Phase 1/2 Trial ("Chip-CRC Trial") [Phase 1, Phase 2]